Geneva Partners’s Humana HUM Stock Holding History

Geneva Partners’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-874	Closed	-$339K	–	87
2020 Q2	$339K	Buy	+874	New	+$327K	0.24%	71

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Geneva Partners's HUM Position: Q3 2020 in Review

Geneva Partners sold out of Humana (HUM) in Q3 2020, closing a stake of 874 shares — an estimated $339K sold.

Geneva Partners first reported a position in HUM in Q2 2020 and held it in 1 quarter. The position peaked at $339K in Q2 2020. 846 funds tracked by Wall St. Rank hold HUM as of Q3 2020.

Geneva Partners reported no remaining Humana position as of Q3 2020 after selling out during the quarter.
Geneva Partners sold 874 Humana shares in Q3 2020, an estimated $339K.
Geneva Partners first reported a position in Humana in Q2 2020 and held it in 1 quarter.
Geneva Partners's Humana position peaked at $339K in Q2 2020.
846 funds tracked by Wall St. Rank held Humana as of Q3 2020.

Based on Geneva Partners's 13F filing for Q3 2020, filed 28 Oct 2020.